Member Info for Joe666

My fear is that they won't want the admin headache and overheads of hundreds of tiny investors. From my limited understanding of private equity a small number of very large investors is the norm. I'm guessing but I'd not be surprised if there's a minimum holding threshold if we go private. I'm also not 100% sure on ISA rules but don't think unlisted securities are acceptable. Whatever happens I agree with Rosewall that this isn't the time to be selling IMHO

The signs don’t look great for us small investors at this stage and I expect the worst, but the picture isn’t completely clear. The 75% agreement is a hurdle for the BoD and if it does go through it’s not certain that existing investors can’t remain invested. Either way it’s an absolute mess.

Well done RT enjoy your weekend

I suppose it becomes about trust in the BoD. They've shown that they are happy to move the goalposts whenever it suits them, would you bet on them not doing it again to possibly make 20% in an unspecified timeframe?

bolarishu, Private equity usually requires a minimum holding which is beyond the reach of most individuals. I have no idea what size your holding is so can't say whether or not this would apply to you. Retail investors can gain exposure to private equity through pooled funds but rarely with direct investment.

bolarishu, You may find yourself being forced out at 6p if it goes private and you don't meet the investor criteria

While it's nice to see BMN (and GGP for that matter) talked about, the standard of coverage from MF is shoddy at best. Thankfully we have some heavyweight researchers on this BB who are willing to share insight and benefit a wider pool of investors.

RT, sorry to be pedantic but you do realise the programme was called Apocalypse Cow? A pun on the title of Francis Ford Coppola's 1979 epic war film.

Here's a link for anyone who hasn't seen it: https://www.channel4.com/programmes/apocalypse-cow-how-meat-killed-the-planet essential viewing for current and potential investors.

About Meatable

Meatable is a Dutch cultivated meat company aiming to deliver at scale cultivated meat that looks like, tastes like, and has the nutritional profile of real meat. Their proprietary Opti-Ox technology enables them to produce the cells needed to make meat rapidly, sustainably, and without harming animals. Founded in 2018, by Krijn de Nood (CEO), Daan Luining (CTO) and Dr. Mark Kotter (Principal Inventor of the Opti-Ox technology). Meatable has a strong team of scientists with unique expertise in fields ranging from tissue mechanics and high-density cell culturing to bioengineering and business strategy.



About Agronomics

Agronomics is an AIM-listed investment company centered on the nascent fields of cellular agriculture, precision fermentation and synthetic biology. The Company invests in technologies that offer new ways of producing food and materials with a focus on products historically derived from animals. These technologies are driving a major disruption in agriculture, offering solutions to improve sustainability, as well as addressing human health, animal welfare and environmental damage. This disruption will decouple supply chains from the environment and animals, as well as being fundamental to feeding the world's expanding population.

Co-lead of Meatable B.V.'s Seed 2 Financing
The Board of Agronomics is pleased to announce today that the Company has co-led Meatable B.V. 's ("Meatable") Seed 2 financing round of approximately €6 million. As part of this round, Agronomics has invested €1 million for 997 Seed 2 Preferred Shares (the "Subscription"). The Subscription will be paid using cash from the Company's own resources.
Agronomics previously invested €2 million in the initial Seed financing round of Meatable in the form of a convertible loan note ("CLN") as announced on 20 December 2019 . Following the Subscription, this CLN will convert to 2,558 Seed 2 Preferred Shares at a 20% discount to the Subscription price. Accordingly, Agronomics will then hold 3,555 Seed 2 Preferred Shares in Meatable at a book value of €3,566,873 and own 6.46% of Meatable on a fully diluted basis.
Richard Reed, Chairman of Agronomics commented: -
"The coronavirus has highlighted that the exploitation of animals for their meat could be a major risk for human health and perversely the stability of the food supply chains. Our confidence is growing that Meatable is a clear differentiated player in the cultivated meat sector which has the potential to end up having a key role in addressing this risk along with the additional benefits to animal welfare and environmental sustainability."
Since Agronomics' initial participation, Meatable has made strong technical progress, including producing both muscle and fat from its reprogrammed Opti-Ox porcine cells, and remains on target for its prototype in Q3 2020.
Krijn de Nood, CEO and co-founder of Meatable, added: -
"We are pleased to secure additional funding, despite the challenging market conditions. This funding will enable us to accelerate our cost reduction, scaling and product development efforts as we prepare for a more significant Series A financing round."
As the Subscription is considered a Substantial Transaction under AIM Rule 12, this announcement requires certain disclosures under Schedule Four. Meatable is an early-stage company, pre-revenue company with cash burn of €228,963 per month and total assets as at 31 March 2020 of approximately €7,350,954 including cash and near cash of €4,909,038.

Fantastic news

Same here, we used to get the odd Micky ramp which was funny. Some of the ramping on Twitter now could be putting potential serious investors off. Using terms like ‘no brainer’ ‘multi bagger’ and ‘choo choo’ with no factual content to back it up doesn’t help anyone’s research.

Loving the positivity today. I'm also in Greatland which has had a fantastic run of late but I remember the quiet years of SP drifting. It paid to be patient on that one and I hope the same will be true here.

Taking just over 5% of the company. Positive.

I hope so too James, you can win and lose a lot in those volatile biotech shares very quickly but the sensible money should eventually find a home in established and profitable growth companies set to capitalise on mega-trends. BMN fits that description perfectly and at this moment £170m market cap with established revenue, cash in the bank and expansion planned and in progress it presents a very attractive entry point for new investors.

barnetpeter, this is classic falling knife, I called it to go to £1 and still think it might happen. That's not to say I think that's fair value but more down to the volatility of GDR ATM. The swings here have been insane and scary enough for seasoned investors let alone the army of newcomers invested here. I got out on Tuesday as did many others, I'm all for a bit of excitement but it had got out of control.

Aim is where dreams are made and dreams are broken.

Fantastic, just don't read the comments!

The whole BoD are crap at PR and the board should support the SP argument is weak.

Good PR is fine but the business should drive the narrative not the other way round. BMN is a commodities & tech company, not a theme park. We know they’re been busy lining up deals in the VRFB market, when these result in actual installations there will be loads of ribbon cutting PR opportunities. As they resume mining and ramp back up to 100% the balance sheet will recover, that will be an another excellent PR op. But right now they’re a small team coming through a crisis that surpasses anything in living memory so let’s put this moaning about lack of news flow in perspective, it is as it should be - business first, PR second. I’ve seen plenty of other AIM shares rise strongly without constant RNS, and others who update weekly only for the price to fall, (it can be seen as desperation) there is no proof it works.

Regarding the BoD supporting the share price It’s a similar weak argument, growing and refining the business will eventually boost the share price. Buybacks, dividends and pointless newsfeeds should not be a priority at this stage for this size of business. Then you have to consider the rules around manipulation that make this a precarious pursuit. I don’t want a BoD that spends energy and time obsessing over SP when they should be growing the business.

Yes, we’re all frustrated with the low SP but please just get some perspective and don’t try to backseat drive this company.

https://www.ft.com/content/e9cf5ed0-a590-4bd6-8c00-b41d0c4ae6e0 Low Covid-19 death toll raises hopes Africa may be spared worst | Free to read